GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 6
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Jeffrey Lehrman, Dpm, DPM | Foot & Ankle Surgery | Fort Collins, CO | $1,510 | $0 |
| Bruce Nicholson, M.d, M.D | Pain Medicine | Allentown, PA | $1,349 | $0 |
| Dr. Mark Dreyer, Dpm, Facafas, DPM, FACAFAS | Military Health Care Provider | Bradenton, FL | $1,345 | $0 |
| Dr. Damon Combs, Dpm, DPM | Foot & Ankle Surgery | Bethel Park, PA | $1,164 | $0 |
| Mark Friedman, Dpm, DPM | Podiatrist | Albany, NY | $1,025 | $0 |
| Dr. Christina Teimouri, Dpm, DPM | Foot & Ankle Surgery | Beaver, PA | $983.14 | $0 |
| Jagdeesh Ullal | Endocrinology, Diabetes & Metabolism | Pittsburgh, PA | $931.63 | $0 |
| Dr. Ashma Davidson, D.p.m, D.P.M | Foot Surgery | Statesville, NC | $856.56 | $0 |
| Dr. Paul Kim, Dpm, DPM | Foot & Ankle Surgery | Dallas, TX | $836.76 | $0 |
| Dr. Kristoffer Ryan De Lara, Md, MD | Interventional Pain Medicine | Germantown, MD | $791.34 | $0 |
| Kelly Wilber, Aprn, APRN | Nurse Practitioner | Waterbury, CT | $771.29 | $0 |
| Kenneth Saag | Rheumatology | Birmingham, AL | $757.50 | $0 |
| Dr. Derrico Quattrone, Dpm, DPM | Foot Surgery | Jefferson Hills, PA | $739.27 | $0 |
| Dr. Christopher Hajnosz, Dpm, DPM | Foot & Ankle Surgery | Pittsburgh, PA | $725.98 | $0 |
| Dr. Lori Paragas, Dpm, DPM | Podiatrist | Hamden, CT | $701.63 | $0 |
| Mrs. Jennifer Martin, Aprn, Fnp-Bc, APRN, FNP-BC | Family | Broken Arrow, OK | $689.26 | $0 |
| Dr. Robert Busch, M.d, M.D | Endocrinology, Diabetes & Metabolism | Albany, NY | $681.28 | $0 |
| Jonathan Labovitz, D.p.m, D.P.M | Podiatrist | Pomona, CA | $652.53 | $0 |
| Jessica Kearney, Np, NP | Primary Care | Edmond, OK | $625.52 | $0 |
| Mrs. Sarah Weller, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C | Family | Riverview, FL | $619.55 | $0 |
| John Stone, M.d, M.D | Internal Medicine | Boston, MA | $562.50 | $0 |
| Dr. Ida Lim, Dpm, DPM | Foot & Ankle Surgery | Matthews, NC | $548.62 | $0 |
| Dr. Charles Hilgenhurst, M.d, M.D | Interventional Pain Medicine | Smyrna, TN | $533.80 | $0 |
| Mr. Jordan Mast, Pa-C, PA-C | Medical | Denver, CO | $527.31 | $0 |
| David Smith, Dpm, DPM | Podiatrist | Clarksville, TN | $525.37 | $0 |
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.